Hims & Hers Announces Definitive Agreement to Acquire YourBio Health

Gunderson Dettmer represented client Hims & Hers, the leading health and wellness platform, in its definitive agreement to acquire YourBio Health, Inc., a Boston-based pioneer in capillary whole blood sampling technology. 

YourBio Health develops technologies designed to simplify the process and expand when, where, and how blood samples can be collected—including beyond traditional clinic settings.

The acquisition will help accelerate efforts to redefine and modernize the overall blood collection experience. Through YourBio’s advanced bladeless microneedle technology, the company aims to establish pain-free blood sampling as the new standard by delivering high-quality capillary blood samples within seconds without the pain or complexity of traditional methods such as fingersticks or venipuncture.  

In the announcement of the acquisition, Hims & Hers founder and CEO Andrew Dudum said, “The next generation of health innovation will be built on proprietary technologies that make wellness simpler, more comfortable, and more human. YourBio’s patented TAP and HALO technologies represent major advancements in user experience and design, and we’re excited to bring them into the Hims & Hers ecosystem.”

The Gunderson deal team was led by corporate partner Alexa Belonick and M&A partner David Moore and included M&A associates Monica Dion and Jordan Hecht, corporate associate Elena Vespoli, strategic transactions and licensing partner Gina Marek and associates Julie Mahoney, Cameron Jahansouz, Gregory Logan, and James Gately, executive compensation partner Sharon Hendricks and associate Sofia Rattes, tax partner Jaime Narayan and associate Tina Xu, and employment and labor partner Natalie Pierce and associate Jordan Simon.